POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 1 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $919,583 | -25.4% | 386,262 | -44.9% | 0.00% | – |
| Q2 2023 | $1,232,527 | -46.9% | 700,526 | -7.1% | 0.00% | -100.0% |
| Q1 2023 | $2,322,864 | +158457.3% | 754,125 | +172.8% | 0.00% | – |
| Q4 2022 | $1,465 | -99.7% | 276,419 | +128.6% | 0.00% | – |
| Q3 2022 | $428,000 | +14.4% | 120,943 | -16.6% | 0.00% | – |
| Q2 2022 | $374,000 | -42.3% | 145,032 | +0.3% | 0.00% | – |
| Q1 2022 | $648,000 | -2.3% | 144,567 | +48.5% | 0.00% | – |
| Q4 2021 | $663,000 | – | 97,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |